-
301
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
Published 2015-01-01“…Seromucinous tumor cells were positive for estrogen receptor (ER) and progesterone receptor (PgR) but negative for Napsin A, p504S, and HNF1B. …”
Get full text
Article -
302
Intravascular Leiomyomatosis as a Rare Cause of Nonthrombotic Pulmonary Embolism
Published 2020-01-01“…Analysis demonstrated a lesion consisting of cells without atypia, showing expression of alpha-smooth muscle actin (alpha SMA) and desmin with partial expression of estrogen receptor (ER) and progesterone receptor (PR), leading to the diagnosis of intravascular leiomyomatosis. …”
Get full text
Article -
303
Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction
Published 2011-01-01“…Several urinary (calcium, phosphate, creatinine, and calcium-to-creatinine ratio) serum (alkaline phosphatase and serum tartrate-resistant acid phosphatase), and molecular markers of bone turnover (receptor activator of NF-κB ligand (RANKL), osteoprotegerin (OPG), and estrogen) were tested. Also, several bone parameters (bone density, bone tensile strength, bone mineral content, and bone histology) and calcium homeostasis were checked. …”
Get full text
Article -
304
Asymptotic analysis of mathematical model describing a new treatment of breast cancer using AZD9496 and palbociclib
Published 2025-01-01“…In this study, the treatment of breast cancer involving a combination of two drugs was investigated: the oral estrogen receptor inhibitor AZD9496 and the CDK4/6 protein inhibitor Palbociclib. …”
Get full text
Article -
305
Pengaruh Faktor Risiko Hormonal pada Pasien Kanker Payudara di RSUP.Dr.M.Djamil Padang
Published 2019-09-01“…Kanker payudara ini berkaitan dengan banyak faktor risiko (multi faktor), salah satunya akibat paparan hormon estrogen. Tujuan penelitian ini adalah menentukan sejauh mana pengaruh faktor risiko hormonal terhadap kanker payudara. …”
Get full text
Article -
306
Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
Published 2011-01-01“…We have previously reported that, in human granulosa cells, thiazolidinediones rosiglitazone and pioglitazone inhibit estrogen synthesis by interfering with androgen binding to aromatase, without an effect on aromatase mRNA or protein expression. …”
Get full text
Article -
307
Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
Published 2024-01-01“…In total, 64 canine mammary tumors were selected to study the most common markers, which are applicable for human breast cancer treatment, including estrogen and progesterone receptors (ER and PR), human epidermal growth factor (HER2/neu), Ki67, and cyclooxygenase 2 (Cox2). …”
Get full text
Article -
308
The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset
Published 2024-01-01“…Findings from our study add to the growing evidence on the potential crosstalk between MET and estrogen receptors in breast cancer. The expression of the MET/ESR genes could be a novel prognosticator and calls for future studies to evaluate the impact of combinational treatment approaches with MET inhibitors and endocrine drugs in breast cancer.…”
Get full text
Article -
309
Exploring the influence of pregnancy on cognitive function in women: a systematic review
Published 2025-01-01“…Abstract Background Pregnancy has been increasingly recognized for its potential impact on cognitive function influenced significantly by hormonal fluctuations such as estrogen and progesterone. However, the findings from research in this area remain debated, often varying with individual factors and pregnancy trimesters. …”
Get full text
Article -
310
Cell signaling communication within papillary craniopharyngioma revealed by an integrated analysis of single-cell RNA sequencing and bulk RNA sequencing
Published 2025-01-01“…Epithelial Mesenchymal Transition, Interferon Gamma Response, p53 Pathway, and Estrogen Response Early are pathways commonly shared by fibroblasts and epithelial cells, ranking high in priority. …”
Get full text
Article -
311
Co-occurrence of a Mullerian anomaly and Kallmann syndrome: A case report
Published 2025-03-01“…She underwent laparoscopic resection of the obstructed right hemiuterus with right salpingectomy. Estrogen replacement therapy was initiated postoperatively with cyclic progestins, and she experienced complete resolution of her pain. …”
Get full text
Article -
312
Anticancer, Antioxidant, Antimicrobial Activities, and HPLC Analysis of Alcoholic Extracts of Parthenocissus quinquefolia L. Plant Collected from Çanakkale
Published 2024-03-01“…Herein, fruit and leaf alcoholic extracts of the plant exhibited anticancer activity on triple negative breast cancer (TNBC) cell lines, estrogen receptor positive (ER+) (MCF-7), and human colon adenocarcinoma (HT-29) cancer cell lines. …”
Get full text
Article -
313
Modeling the endocrine control of vitellogenin production in female rainbow trout
Published 2013-12-01“…Numerical simulation results based on this model are comparedwith experimental data for estrogen receptor mRNA, Vg mRNA, and Vgin the plasma from female rainbow trout over a normal annual reproductivecycle. …”
Get full text
Article -
314
Curcumin Relieves Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior through the PGC-1α/FNDC5/BDNF Pathway
Published 2021-01-01“…The expressions of PGC-1α, estrogen-related receptor alpha (ERRα), FNDC5, and BDNF were determined to investigate the regulatory effects of CUR on the PGC-1α/FNDC5/BDNF pathway. …”
Get full text
Article -
315
Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentia...
Published 2025-01-01“…Abstract Breast cancer (BC) is classified based on the expression of histopathological markers, namely, estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2). …”
Get full text
Article -
316
Genetics of Endometrial Cancers
Published 2010-01-01“…The most frequently altered gene in estrogen-dependent endometrioid endometrial carcinoma tumors is PTEN. …”
Get full text
Article -
317
Correlating NAD(P)H lifetime shifts to tamoxifen resistance in breast cancer cells: A metabolic screening study with time-resolved flow cytometry
Published 2025-01-01“…Time-resolved flow cytometry (TRFC) was used to measure metabolic differences in estrogen receptor-positive breast cancer cells. This specialty cytometry technique measures fluorescence lifetimes as a single-cell parameter thereby providing a unique approach for high-throughput cell counting and screening. …”
Get full text
Article -
318
A review of Psoralea corylifolia L.: a valuable plant with profound biological significance
Published 2025-01-01“…PCL and related products have demonstrated therapeutic effects, such as antiosteoporosis effects, estrogen-like effects, anti-inflammatory properties, neuroprotection, antitumor activity, and vitiligo treatment. …”
Get full text
Article -
319
Differentially expressed whey proteins of donkey and bovine colostrum revealed with a label-free proteomics approach
Published 2023-07-01“…Metabolic pathway analysis suggested that the majority of the DEWPs were associated with soluble NSF factor attachment protein receptor interactions in vesicular transport, fatty acid biosynthesis, and estrogen signaling pathways. Our results provide a vital insight into the differences between donkey and bovine colostrum, along with important information on the significant components as nutritional and functional factors to be included in infant formula based on multiple milk sources.…”
Get full text
Article -
320
Risk factors for coronary atherosclerotic heart disease in postmenopausal women: a meta-analysis
Published 2025-01-01“…Approximately 3.8 million women die from CHD every year globally. After menopause, estrogen levels decrease, and the risk of cardiovascular disease increases substantially; however, research on risk factors for CHD in postmenopausal women has been inconclusive.ObjectiveTo systematically evaluate the risk factors for CHD in postmenopausal women.MethodsThe PubMed, Embase, Web of Science, CINAHL, CBM, CNKI, and VIP databases were searched up to February 9, 2024, for studies on risk factors for CHD in postmenopausal women. …”
Get full text
Article